Avante, a Seattle-based startup, has raised $10 million in seed funding. FUSE, a leading venture capital firm headquartered in Bellevue, WA, spearheaded the funding round. The round is set to propel Avante’s ambitious goals of revolutionizing enterprise software.
Avante, founded by former OliveAI executives Rohan D’Souza and Carly Eckert, MD, Ph.D., is charting a course toward a groundbreaking solution in enterprise software. With a core team that includes Kabir Shahani, former CEO of Amperity, Avante aims to tap into one of the largest untapped categories in the sector.
The $10 million will catalyze Avante’s product development, engineering, and data science teams. The strategic decision to back Avante was based on the startup’s astute assessment of industry challenges and its innovative technical approach.
While operating under stealth, Avante has been actively recruiting top-tier talent. The company focuses on enhancing employee well-being through advanced analytics and behavior change. The startup’s formal name, Avante Health Inc., and its registration filing indicate a mission to be an “employee intelligence platform,” addressing a problem that affects both companies and individuals. Avante plans to quadruple its core development team over the next 12 months, demonstrating a commitment to rapid growth and market impact.
“We made our decision to fund Avante for three reasons: Avante’s spot-on assessment of the issue, its technical approach, and the strength and experience of Rohan D’Souza, Kabir Shahani, and the early team,” expressed Kellan Carter.
This substantial seed funding comes at a crucial time, as Avante seeks to redefine enterprise software and make a significant economic impact on its customers. This funding positions Avante as a key player in the enterprise software arena, leveraging the expertise of its leadership team and a robust approach to addressing industry challenges. The startup’s vision and commitment to innovation signal a promising future in the rapidly evolving technology landscape.